271 related articles for article (PubMed ID: 27321544)
1. Are proton pump inhibitors really so dangerous?
Savarino V; Dulbecco P; Savarino E
Dig Liver Dis; 2016 Aug; 48(8):851-9. PubMed ID: 27321544
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
Cohen S; Bueno de Mesquita M; Mimouni FB
Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
[TBL] [Abstract][Full Text] [Related]
3. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
4. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.
Hershcovici T; Fass R
Drugs; 2011 Dec; 71(18):2381-9. PubMed ID: 22117130
[TBL] [Abstract][Full Text] [Related]
5. Medical therapy for gastroesophageal reflux disease in 2007.
Katz PO
Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
[TBL] [Abstract][Full Text] [Related]
6. Alternative therapeutic approaches to chronic proton pump inhibitor treatment.
Fass R
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):338-45; quiz e39-40. PubMed ID: 22178462
[TBL] [Abstract][Full Text] [Related]
7. Acid suppression therapy: where do we go from here?
Scarpignato C; Pelosini I; Di Mario F
Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
[TBL] [Abstract][Full Text] [Related]
8. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
9. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor use and enteric infections.
Dial MS
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
[TBL] [Abstract][Full Text] [Related]
11. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
12. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
Juul-Hansen P; Rydning A
Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
[TBL] [Abstract][Full Text] [Related]
13. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
14. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
Kawai T; Yagi K; Moriyasu F
Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
[TBL] [Abstract][Full Text] [Related]
15. A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants.
Tan J; Jeffries S; Carr R
Paediatr Drugs; 2023 Sep; 25(5):557-576. PubMed ID: 37458926
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.
Lam JR; Schneider JL; Zhao W; Corley DA
JAMA; 2013 Dec; 310(22):2435-42. PubMed ID: 24327038
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor prescribing and costs in a large outpatient clinic.
Hood W; McJunkin B; Warnock A; Girme A; Smith N; Robinson B
W V Med J; 2014; 110(1):16-21. PubMed ID: 24640269
[TBL] [Abstract][Full Text] [Related]
18. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.
Bell JC; Schneuer FJ; Harrison C; Trevena L; Hiscock H; Elshaug AG; Nassar N
Arch Dis Child; 2018 Jul; 103(7):660-664. PubMed ID: 29472195
[TBL] [Abstract][Full Text] [Related]
19. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.
Ruscin JM; Page RL; Valuck RJ
Ann Pharmacother; 2002 May; 36(5):812-6. PubMed ID: 11978157
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma.
Papagerakis S; Bellile E; Peterson LA; Pliakas M; Balaskas K; Selman S; Hanauer D; Taylor JM; Duffy S; Wolf G
Cancer Prev Res (Phila); 2014 Dec; 7(12):1258-69. PubMed ID: 25468899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
